{"id":46141,"date":"2022-07-13T18:02:18","date_gmt":"2022-07-13T16:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/"},"modified":"2022-07-13T18:02:18","modified_gmt":"2022-07-13T16:02:18","slug":"kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/","title":{"rendered":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR<\/a>) (OTCQB:KNRLF<\/a>) (FSE:1K8<\/a>) (\u201cKontrol<\/b>\u201d or the \u201cCompany<\/b>\u201d) announces that its operating subsidiary – CEM Specialties Inc. – is receiving advisory services and funding of up to $300,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP<\/b>“) supporting a research and development project to accelerate its new wastewater testing technology, the Kontrol BioWater analyzer (“BioWater analyzer<\/b>” or “Kontrol BioWater<\/b>“), for the detection of viruses including COVID-19.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are pleased to continue to add to our growing technology platform and intellectual property as we advance the Kontrol BioWater to the next stage of its development,\u201d says Paul Ghezzi, CEO, Kontrol Technologies.\n<\/p>\n

\nKontrol BioWater Innovation<\/b>\n<\/p>\n

\nThe Kontrol BioWater technology will be designed with the goal of being the first real-time, in the cloud, detection technology for virus in wastewater. The current process for the collection of wastewater sampling involves on-site technicians, transporting samples to a laboratory and then undertaking a separate analysis of the wastewater. This process is time consuming and can take several days to complete. The intention of the Kontrol BioWater is to advance sampling automation for faster, on-site detection which can potentially accelerate a response plan.\n<\/p>\n

\n\u201cEarly viral detection is in its infancy, and we continue to build our BioCloud technology which will now include Kontrol BioWater,\u201d says Gary Saunders, President of Kontrol BioCloud.\n<\/p>\n

\nAccording to the following statement from the United States Centers for Disease Control (\u201cCDC<\/b>\u201d) and Prevention, wastewater surveillance can provide an early warning of COVID-19\u2019s spread in communities. To learn more visit www.cdc.gov\/healthywater\/surveillance.com<\/a>\n<\/p>\n

\nAs per the CDC, \u201cThe virus can then be detected in wastewater, enabling wastewater surveillance to capture presence of SARS-CoV-2 shed by people with and without symptoms. This allows wastewater surveillance to serve as an early warning that COVID-19 is spreading in a community. Once health departments are aware, communities can act quickly to prevent the spread of COVID-19. Data from wastewater testing support public health mitigation strategies by providing additional crucial information about the prevalence of COVID-19 in a community.\u201d<\/i>\n<\/p>\n

\nThe Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain COVID-19 (or SARS-2 Coronavirus).\n<\/p>\n

\nAbout Kontrol BioCloud\u00ae<\/b>\n<\/p>\n

\nKontrol BioCloud (\u201cBioCloud<\/b>\u201d) is an operating subsidiary of Canadian public company Kontrol Technologies Corp. The BioCloud technology is a real-time analyzer designed to detect airborne viruses and pathogens. BioCloud is an air quality technology and not a medical device. BioCloud has been designed to operate as a safe space technology by sampling the air quality continuously. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com<\/a>\n<\/p>\n

\nKontrol BioWater is a technology extension of the Kontrol BioCloud and will be developed to operate as a branded solution for water monitoring applications.\n<\/p>\n

\nKontrol Technologies Corp.<\/b>\n<\/p>\n

\nKontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides solutions and services to its customers to improve energy management, monitor continuous emissions and accelerate the sustainability of all buildings.\n<\/p>\n

\nAdditional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com<\/a> and by reviewing its profile on SEDAR at www.sedar.com<\/a>\n<\/p>\n

\nNeither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.<\/b>\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis news release contains \u201cforward-looking information\u201d within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as \u201cmay\u201d, \u201cwill\u201d, \u201cexpect\u201d, \u201clikely\u201d, \u201cshould\u201d, \u201cwould\u201d, \u201cplan\u201d, \u201canticipate\u201d, \u201cintend\u201d, \u201cpotential\u201d, \u201cproposed\u201d, \u201cestimate\u201d, \u201cbelieve\u201d or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions \u201cmay\u201d or \u201cwill\u201d happen, or by discussions of strategy. Forward-looking information contained in this press releases includes, but is not limited to, the following: future testing to be conducted by Kontrol of its products; the future success of any of Kontrol\u2019s products; and customer demand relating to air quality and water testing products.<\/i>\n<\/p>\n

\nWhere Kontrol expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company; that future testing can be conducted as planned; that technology will be as effective as anticipated; that existing relationships and contracts entered into by the Company will continue on the same or similar terms, or at all; and that demand will continue for air quality or water monitoring products and for the Company\u2019s products in particular.<\/i>\n<\/p>\n

\nHowever, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all; that the Company\u2019s technologies will not prove as effective as expected; that customers and potential customers will not be as accepting of the Company’s product and service offering as expected and\/or that demand for such products and services will not continue; that the Company\u2019s test results will not be replicated in the future or that future testing will not be conducted; that the Company will not maintain its existing relationships or contracts on the same terms or at all; and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).<\/i>\n<\/p>\n

\nAccordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKontrol Technologies Corp.<\/b>
Paul Ghezzi
\n
CEO
\n
info@kontrolcorp.com<\/a>
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
\n
Tel: (905) 766.0400\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (\u201cKontrol\u201d or the \u201cCompany\u201d) announces that its operating subsidiary – CEM Specialties Inc. – is receiving advisory services and funding of up to $300,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP“) supporting a research and development project to accelerate its new wastewater … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46141","6":"format-standard","7":"category-industry"},"yoast_head":"\nKontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (\u201cKontrol\u201d or the \u201cCompany\u201d) announces that its operating subsidiary – CEM Specialties Inc. – is receiving advisory services and funding of up to $300,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP“) supporting a research and development project to accelerate its new wastewater ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-13T16:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology\",\"datePublished\":\"2022-07-13T16:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/\"},\"wordCount\":1153,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005664\\\/en\\\/1231614\\\/21\\\/Kontrol_Technologies_Corp.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/\",\"name\":\"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005664\\\/en\\\/1231614\\\/21\\\/Kontrol_Technologies_Corp.jpg\",\"datePublished\":\"2022-07-13T16:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005664\\\/en\\\/1231614\\\/21\\\/Kontrol_Technologies_Corp.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220713005664\\\/en\\\/1231614\\\/21\\\/Kontrol_Technologies_Corp.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/","og_locale":"en_US","og_type":"article","og_title":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend","og_description":"TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (\u201cKontrol\u201d or the \u201cCompany\u201d) announces that its operating subsidiary – CEM Specialties Inc. – is receiving advisory services and funding of up to $300,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP“) supporting a research and development project to accelerate its new wastewater ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-13T16:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology","datePublished":"2022-07-13T16:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/"},"wordCount":1153,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/","url":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/","name":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg","datePublished":"2022-07-13T16:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220713005664\/en\/1231614\/21\/Kontrol_Technologies_Corp.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kontrol-announces-funding-to-accelerate-the-development-of-kontrol-biowater-a-real-time-viral-testing-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46141"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46141\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}